The Allstate Co. (NYSE:ALL – Get Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 2,370,000 shares, a growth of 17.3% from the November 15th total of 2,020,000 shares. Based on an average daily volume of 1,490,000 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.9% of the shares of the stock are short sold.
Insider Buying and Selling
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 1.80% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. FSA Wealth Management LLC acquired a new position in Allstate during the third quarter valued at approximately $26,000. Northwest Investment Counselors LLC acquired a new position in shares of Allstate in the third quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new position in shares of Allstate in the third quarter valued at about $29,000. Family Firm Inc. acquired a new stake in shares of Allstate during the 2nd quarter worth about $38,000. Finally, Transamerica Financial Advisors Inc. acquired a new position in Allstate in the 3rd quarter valued at about $58,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.81 earnings per share. As a group, research analysts predict that Allstate will post 16.26 EPS for the current year.
Allstate Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be given a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.88%. Allstate’s payout ratio is 23.83%.
Analyst Ratings Changes
Several research firms have recently commented on ALL. Raymond James boosted their price target on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a report on Friday, October 4th. Morgan Stanley increased their price objective on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. TD Cowen boosted their target price on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. The Goldman Sachs Group raised their price target on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a report on Friday, November 15th. Finally, JPMorgan Chase & Co. increased their target price on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and a consensus target price of $217.19.
Get Our Latest Research Report on Allstate
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- How to Start Investing in Real Estate
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Dividend Payout Ratio Calculator
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Golden Cross Stocks: Pattern, Examples and Charts
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.